Market Cap 121.99M
Revenue (ttm) 53.40M
Net Income (ttm) 2.93M
EPS (ttm) N/A
PE Ratio 22.00
Forward PE 8.56
Profit Margin 5.49%
Debt to Equity Ratio 0.00
Volume 240,600
Avg Vol 847,530
Day's Range N/A - N/A
Shares Out 79.73M
Stochastic %K 51%
Beta -0.21
Analysts Strong Sell
Price Target $14.00

Company Profile

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 696 9345
Address:
2 University Plaza, Suite 100, Hackensack, United States
jeremy0916
jeremy0916 Aug. 21 at 1:08 AM
$PLX Nice fb ad.
0 · Reply
Social_Idiot
Social_Idiot Aug. 20 at 10:11 PM
$PLX Very interesting.... Gout + NETs? Click downlaod this paper to get the full paper which is still under review. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4926027
1 · Reply
zoomlik
zoomlik Aug. 20 at 8:15 PM
$PLX Looking better each day
1 · Reply
Artfldgr
Artfldgr Aug. 20 at 4:46 PM
$PLX The current CHMP written-procedure agenda (Aug 18–21, 2025) doesn’t list Elfabrio/pegunigalsidase alfa anywhere. Elfabrio last showed up earlier this year as a Type II variation (II/0007) to introduce an alternative Q4W dosing, based on BRIGHT and its extension—first in January and then again in June under post-authorisation issues (“Action: For adoption”). CHMP’s official schedule shows the August session (this week) and then Sept 15–18 as the next plenary; there’s no CHMP note about any Elfabrio decision being “scheduled to be announced at the end of the month.”
1 · Reply
m2025
m2025 Aug. 20 at 3:07 PM
$PLX What is the next event that can move us?
1 · Reply
CrytpoConverter
CrytpoConverter Aug. 20 at 2:20 PM
$PLX Still holding long and strong been here since 11/23 😅👌 our time WILL come.
0 · Reply
Artfldgr
Artfldgr Aug. 20 at 2:15 PM
$PLX on the free giveaway since its quiet here today [half the hard part is knowing what to look for before you look]
6 · Reply
Artfldgr
Artfldgr Aug. 20 at 2:12 PM
$PLX When many people independently guess an outcome (like the weight of an object), their individual errors often cancel each other out. Some guess too high, others too low, but when averaged, the random over- and under-estimations balance. This is called the wisdom of crowds. It works best when guesses are made independently, people have diverse perspectives, and no single bias dominates the group. The average ends up surprisingly accurate, often closer than most individual guesses. Averaging crowd predictions may offer some insight in highly liquid markets for short-term movements, but it's generally not reliably accurate for predicting stock closes and shouldn’t replace solid analysis or risk management. So its a play for information (in this case, google will give them your data if they identify you)
0 · Reply
ed29
ed29 Aug. 20 at 1:25 PM
$PLX Off topic, has anyone here heard of a way of generating electricity with a battery and running a motor non stop for 15 years? Apparently one can extract free radiant energy from the vacumm. Radiant Energy is brought into the environment everytime a magnetic wave collapses. This electrostatic burst is reactive power unusable by conventional means. Wasted and abundent and available literally everywhere. Sharing something that the intellects on this channel will prb enjoy and more than likely already know about. At the same time triggering the self proclaimed policy makers / virual police officers that still think people get in "trouble" As I see it, you are only in trouble if "YOU THINK YOU ARE" Not because someone tries to convince you. I havent been in trouble one single time since I learned this : ) https://www.linkedin.com/posts/limitless-potential-technologies_science-physics-engineering-activity-7350332134655414272-Iav8/
1 · Reply
PLX_BULLS
PLX_BULLS Aug. 20 at 2:28 AM
$PLX From Strong Buy to Buy by CFRA…
1 · Reply
Latest News on PLX
Protalix BioTherapeutics Issues 2025 Letter to Stockholders

Dec 23, 2024, 6:50 AM EST - 8 months ago

Protalix BioTherapeutics Issues 2025 Letter to Stockholders


Protalix BioTherapeutics Issues 2024 Letter to Stockholders

Dec 26, 2023, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics Issues 2024 Letter to Stockholders


jeremy0916
jeremy0916 Aug. 21 at 1:08 AM
$PLX Nice fb ad.
0 · Reply
Social_Idiot
Social_Idiot Aug. 20 at 10:11 PM
$PLX Very interesting.... Gout + NETs? Click downlaod this paper to get the full paper which is still under review. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4926027
1 · Reply
zoomlik
zoomlik Aug. 20 at 8:15 PM
$PLX Looking better each day
1 · Reply
Artfldgr
Artfldgr Aug. 20 at 4:46 PM
$PLX The current CHMP written-procedure agenda (Aug 18–21, 2025) doesn’t list Elfabrio/pegunigalsidase alfa anywhere. Elfabrio last showed up earlier this year as a Type II variation (II/0007) to introduce an alternative Q4W dosing, based on BRIGHT and its extension—first in January and then again in June under post-authorisation issues (“Action: For adoption”). CHMP’s official schedule shows the August session (this week) and then Sept 15–18 as the next plenary; there’s no CHMP note about any Elfabrio decision being “scheduled to be announced at the end of the month.”
1 · Reply
m2025
m2025 Aug. 20 at 3:07 PM
$PLX What is the next event that can move us?
1 · Reply
CrytpoConverter
CrytpoConverter Aug. 20 at 2:20 PM
$PLX Still holding long and strong been here since 11/23 😅👌 our time WILL come.
0 · Reply
Artfldgr
Artfldgr Aug. 20 at 2:15 PM
$PLX on the free giveaway since its quiet here today [half the hard part is knowing what to look for before you look]
6 · Reply
Artfldgr
Artfldgr Aug. 20 at 2:12 PM
$PLX When many people independently guess an outcome (like the weight of an object), their individual errors often cancel each other out. Some guess too high, others too low, but when averaged, the random over- and under-estimations balance. This is called the wisdom of crowds. It works best when guesses are made independently, people have diverse perspectives, and no single bias dominates the group. The average ends up surprisingly accurate, often closer than most individual guesses. Averaging crowd predictions may offer some insight in highly liquid markets for short-term movements, but it's generally not reliably accurate for predicting stock closes and shouldn’t replace solid analysis or risk management. So its a play for information (in this case, google will give them your data if they identify you)
0 · Reply
ed29
ed29 Aug. 20 at 1:25 PM
$PLX Off topic, has anyone here heard of a way of generating electricity with a battery and running a motor non stop for 15 years? Apparently one can extract free radiant energy from the vacumm. Radiant Energy is brought into the environment everytime a magnetic wave collapses. This electrostatic burst is reactive power unusable by conventional means. Wasted and abundent and available literally everywhere. Sharing something that the intellects on this channel will prb enjoy and more than likely already know about. At the same time triggering the self proclaimed policy makers / virual police officers that still think people get in "trouble" As I see it, you are only in trouble if "YOU THINK YOU ARE" Not because someone tries to convince you. I havent been in trouble one single time since I learned this : ) https://www.linkedin.com/posts/limitless-potential-technologies_science-physics-engineering-activity-7350332134655414272-Iav8/
1 · Reply
PLX_BULLS
PLX_BULLS Aug. 20 at 2:28 AM
$PLX From Strong Buy to Buy by CFRA…
1 · Reply
flyinghollaender
flyinghollaender Aug. 19 at 6:41 PM
$OTLK sold it (maybe too early) $PLX huge position and ready to buy more in case it drops. 3$ minimum at the end of this year
0 · Reply
CrytpoConverter
CrytpoConverter Aug. 19 at 6:13 PM
$PLX i dont understand how this is trading at current share price. This is great opportunity to buy, so much upwards from here. Buy. Hold. Chill. Buy. Buy. Chill. Hold. Win.
0 · Reply
charleston_invest
charleston_invest Aug. 19 at 4:35 PM
$PLX Let's say 4 wk treatment plan gets approved. Does anyone fear that doctor's offices might not make this treatment option known (including switching from Fabrazyme) to their patients out of fear of losing steady lucrative business? I think the statistic is that only about a 1/3 of patients infuse at home. I know we all like to think Doctors are altruistic and follow a Hippocratic oath, but they want to make a living as well.
8 · Reply
Social_Idiot
Social_Idiot Aug. 19 at 3:45 PM
$PLX Recent study suggest a much higher undiagnosed Fabry population: https://www.medrxiv.org/content/10.1101/2024.12.13.24319001v1.full
0 · Reply
Social_Idiot
Social_Idiot Aug. 19 at 3:40 PM
$PLX If Medicaid shows 32 prescriptions for Elfabrio and 26% of population is on Medicaid, the projection would be 120+ prescriptions in the US and at ~4-5k Fabry patients, that would be 2.4-3.0+% market penetration.
1 · Reply
Artfldgr
Artfldgr Aug. 19 at 3:26 PM
$PLX @MinorLeagueTrader When the math beat you, you reached for insults — that’s what a child does when the gun is empty. You live on hunches. I live on experience, logic, consistency, results, and a track record that speaks louder than your deflections. If I’m wrong, the numbers will show it. If you’re wrong, your hunch vanishes into smoke. Only one of us can be measured. I backed up my words, not showed off what was in my accounts (there are many others i dont show) “Dime store psychology”? Maybe that’s your practice. Mine is backed by numbers and reality. The only thing cheap here was your attempt to dodge when facts left you cornered. You offered me a cookie. Cute. But I’m the one with the recipe, the bakery, and the line of customers. You’re just standing outside hungry Did anyone tell you your so cute when your angry?
1 · Reply
charleston_invest
charleston_invest Aug. 19 at 2:46 PM
$PLX All the discussions are basically mute at the moment - we are range bound between $1.45-1.55 (really hard to believe this last quarter reporting which was good... no other way to describe it, did not break this $1.55 ceiling we have been in since March). The only known catalyst ( not counting BO, M&A, and PRX-115 outstanding results speculations) is the EMA decision on 4 wk treatment regimen which can break this doldrum. I can only hope ( I know some object to the use of the word hope) that we wake up some morning in the near future to find that this has been given the blessing by the CHMP so this suppressed stock can soar.
3 · Reply
Artfldgr
Artfldgr Aug. 19 at 1:03 PM
$PLX Here is the fun part for any of you that care to play a game. If anyone has some really good questions, not silly ones or ones with emotional cues, but good solid questions (that dont screw up my neutral model), I will pose them to the engine. ALL i asked to get this was: The objective is to detect decline in fabryyme through analysis of intraday numbers, quarterly reports, balance sheets, etc... the goal is to try to figure out how much SNY is being affected by the incursion of PLX Elfabrio [the AI as a lot more orders and stuff to insure accuracy and not to try to make me happy, etc. way too much stuff to post and to explain in such short post areas as this] And it put out a lot more i am not posting as it would take too long and too much space and i am not exactly loved here anyway. (not that i would like that, its creepy).
1 · Reply
Artfldgr
Artfldgr Aug. 19 at 12:59 PM
$PLX This is one of the most complicated analysis i have done to date... the AI has over 5 years of PLX data & SNY data Intraday to 1 min, news, sentiment data, reports, and tons of other stuff, not including what a paid account could retrieve on its own with the new engine
1 · Reply
Artfldgr
Artfldgr Aug. 19 at 12:35 PM
$PLX AI Analysis [feeding it two years of SNY data, will have more in a few minutes]
0 · Reply
jcon777
jcon777 Aug. 19 at 2:01 AM
$PLX Per Grok, "Protalix’s Q3 2025 earnings are scheduled for release on November 13, 2025." "Analysts estimate an EPS of $0.11 for Q3 2025."
3 · Reply
pmcd777
pmcd777 Aug. 18 at 11:22 PM
$PLX https://www.businesswire.com/news/home/20250814528346/en/AceLink-Therapeutics-Completes-6-Month-Primary-Phase-of-AL01211-Clinical-Study-in-Fabry-Disease-Patients
3 · Reply